Malavika Kaur Makol Bloomberg
- All
- News
-
RBI Not Planning Harsher Rules to Curb Fintech Sector After Paytm Strictures, Official Says
The Reserve Bank of India does not plan to impose drastic measures on India's fintech sector after the recent action against Paytm Payments Bank, according to P Vasudevan, an executive director in charge of enforcement at the central bank. Paytm has been in the crosshairs of the regulator for some time, with multiple warnings over the past two year...
-
Tomatoes Are The Next Big Risk To PM Modi's Fight Against Inflation
Tomato prices are surging in India, putting politicians on notice as vegetables have an unusual history of toppling governments in the country.
-
Government Hopes This City Will Break China's Grip On Pharma Industry
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
-
India's Race To Vaccinate Its Villages Is Crucial For Whole World
One of the largest COVID-19 vaccination drives in the world, India's campaign ever since January to vaccinate its 1.4 billion citizens has hit snag after snag, held back first by shortages and then by chaotic distribution..
-
Forecaster Who Predicted India's Covid Peak Sees New, Smaller Wave Ahead
India is likely to see a rise in Covid-19 infections building into a new -- though smaller -- virus wave that may peak in October, according to a mathematical model by researchers who accurately predicted the tapering of a brutal surge of cases earli
-
Poorer Indian Women Lost More Jobs, Ate Less Amid The Pandemic
Women in India's low-income households lost jobs more often compared to men, cut back on their food intake as well as rest and provided more unpaid care work, according to a study by consulting firm Dalberg.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
-
RBI Not Planning Harsher Rules to Curb Fintech Sector After Paytm Strictures, Official Says
The Reserve Bank of India does not plan to impose drastic measures on India's fintech sector after the recent action against Paytm Payments Bank, according to P Vasudevan, an executive director in charge of enforcement at the central bank. Paytm has been in the crosshairs of the regulator for some time, with multiple warnings over the past two year...
-
Tomatoes Are The Next Big Risk To PM Modi's Fight Against Inflation
Tomato prices are surging in India, putting politicians on notice as vegetables have an unusual history of toppling governments in the country.
-
Government Hopes This City Will Break China's Grip On Pharma Industry
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
-
India's Race To Vaccinate Its Villages Is Crucial For Whole World
One of the largest COVID-19 vaccination drives in the world, India's campaign ever since January to vaccinate its 1.4 billion citizens has hit snag after snag, held back first by shortages and then by chaotic distribution..
-
Forecaster Who Predicted India's Covid Peak Sees New, Smaller Wave Ahead
India is likely to see a rise in Covid-19 infections building into a new -- though smaller -- virus wave that may peak in October, according to a mathematical model by researchers who accurately predicted the tapering of a brutal surge of cases earli
-
Poorer Indian Women Lost More Jobs, Ate Less Amid The Pandemic
Women in India's low-income households lost jobs more often compared to men, cut back on their food intake as well as rest and provided more unpaid care work, according to a study by consulting firm Dalberg.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
